Press and Media
Article: Finding a world-class manufacturing partner for the aseptic filling of biologics
Finding a world-class manufacturing partner for the aseptic filling of biologics that offers flexibility and precision in their work, while being able to meet today’s complex regulatory requirements, is never an easy task. Vetter’s managing director, Peter Soelkner, offers insight on how to navigate this process and choose the best CDMO for the job.
Most biotechnology companies involved in the aseptic filling of biologics have a difficult time narrowing the field of biologic manufacturers to help them select the right one for their particular needs. This is especially true when an increase in production is necessary. After all, that is the reason many companies outsource in the first place. Peter Soelkner, managing director of Vetter, believes being flexible and able to respond to a client’s current needs is critical to meeting their future needs as well. Soelkner shares his thoughts with the editor of Pharmaceutical Online and Bioresearch in an article appearing in the January 28, edition.